IDEAYA Biosciences: Pay

IDEAYA Biosciences paid its 6 named executives $23.1M in total in FY2025 (Dec). CEO Yujiro S. Hata was paid $9.5M of that.

Pay$100 in the stock at the end of FY20 → $247
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Yujiro S. HataPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Joshua Bleharski, Ph.D.Chief Financial Officer
FY2025 (Dec)
1 year
Darrin M. Beaupre, M.D., Ph.D.Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Michael A. White, Ph.D.Chief Scientific Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Andres Ruiz BrisenoChief Accounting Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Douglas B. SnyderChief Legal Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

No CEO pay of the disclosed peers is on file for FY2023 (Dec).

  1. 1IDEAYA Biosciences
  2. 2ALX Oncology Holdings, Inc.Not disclosed
  3. 3C4 Therapeutics, Inc.Not disclosed
  4. 4Crinetics Pharmaceuticals, Inc.Not disclosed
  5. 5Erasca, Inc.Not disclosed
  6. 6Gossamer Bio, Inc.Not disclosed
  7. 7Imago BioSciences, Inc.Not disclosed
  8. 8Inhibrx, Inc.Not disclosed
  9. 9Iteos Therapeutics, Inc.Not disclosed
  10. 10Jounce Therapeutics, Inc.Not disclosed
  11. 11KalVista Pharmaceuticals, Inc.Not disclosed
  12. 12Kezar Life Sciences Inc.Not disclosed
  13. 13Kura Oncology, Inc.Not disclosed
  14. 14Mersana Therapeutics, Inc.Not disclosed
  15. 15Nurix Therapeutics, Inc.Not disclosed
  16. 16ORIC Pharmaceuticals, Inc.Not disclosed
  17. 17PMV Pharmaceuticals, Inc.Not disclosed
  18. 18Precision BioSciences, Inc.Not disclosed
  19. 19RAPT Therapeutics, Inc.Not disclosed
  20. 20Replimune Group Inc.Not disclosed
  21. 21Sutro Biopharma, Inc.Not disclosed
  22. 22Zentalis Pharmaceuticals, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.